Why Are Fertility Preservation Patients Not Coming Back?
Why Are They Not Coming Back? A Single-center Follow-up Study in Fertility Preservation in Oncological Women.
1 other identifier
observational
172
1 country
1
Brief Summary
This is a single-center retrospective study carried out with a phone call follow-up to investigate women's decision not to return for criopreserved ovocytes use after cancer treatment. The study database includes all women who underwent fertility preservation cycles at a third-level university-affiliated center from January 2001 to December 2017. Patients were asked a set of standardized questions whose purpose was to investigate their present health conditions, cancer treatment and any potential relapses, their family projects and sentimental status, any spontaneous conception, and why they had not yet returned for embryo transfer. All data were recorded anonymously in our dataset.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 24, 2022
CompletedFirst Posted
Study publicly available on registry
February 4, 2022
CompletedFebruary 4, 2022
January 1, 2022
7 months
January 24, 2022
January 24, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
return rate
return rate of cancer patients who underwent fertility preservation
from January 2001 to December 2021
Study Arms (1)
Fertility preservation population
all women who underwent oocyte cryopreservation cycles for oncological purposes from January 2001 to December 2017 at Fertility Center of Humanitas Research Hospital, Rozzano (Milano), Italy
Interventions
phone call follow-up to investigate women's decision not to return for embryo transfer after cancer treatment.
Eligibility Criteria
Women with an oncological diagnosis who underwent ovarian stimulation and oocytes retrivial and cryopreservation for fertility preservation
You may qualify if:
- The study database includes all women who underwent fertility preservation cycles at a third-level university-affiliated center
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Valentina Immediata
Milan, MI, 20141, Italy
Related Publications (1)
Immediata V, Cirillo F, Baggiani A, Zanagnolo MF, Ronchetti C, Morenghi E, Cesana A, Specchia C, Levi-Setti PE. Why are they not coming back? A single-center follow-up study on oncological women oocyte's storing for fertility preservation. Front Endocrinol (Lausanne). 2022 Dec 6;13:1054123. doi: 10.3389/fendo.2022.1054123. eCollection 2022.
PMID: 36561560DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2022
First Posted
February 4, 2022
Study Start
June 1, 2021
Primary Completion
December 31, 2021
Study Completion
January 1, 2022
Last Updated
February 4, 2022
Record last verified: 2022-01